Finally, a vaccine for one of the deadliest forms of cancer
1 min read
Image credit: koto_feja / Getty Images. Article by Julia Pugachevsky. Insider – May 10, 2023.
- A small new study led by BioNTech used a customized pancreatic cancer vaccine on 16 patients.
- Half of the patients remained cancer-free after 18 months.
- Competitors like Moderna have also been developing personalized mRNA cancer vaccines.
A new vaccine designed to treat pancreatic cancer prevented the disease from returning in 50% of patients who received it, scientists reported today.